FDA Inspection 1315412 — Lenox Hill Hospital

Lenox Hill Hospital — FEI 2470633

The FDA completed an inspection of Lenox Hill Hospital on April 29, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 29, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)